grant

Cancer Immunotherapy utilizing a novel receptor for Programmed cell death-1 ligand 2 [ 2016 - 2017 ]

Research Grant

[Cite as https://purl.org/au-research/grants/nhmrc/1113888]

Researchers: Dr Michelle Wykes (Principal investigator) ,  Prof Arlene Sharpe

Brief description Immuno-modulators utilize the patient’s own immune system to eliminate or slow the growth of cancerous cells. We have identified a novel immuno-modulator which could be a significant player in immune-modulation therapy for the treatment of cancer. We will use the development grant to develop a product which has significant potential to be the next generation treatment for cancer.

Funding Amount $AUD 577,857.41

Funding Scheme Development Grants

Notes Development Grant

Click to explore relationships graph
Identifiers
Viewed: [[ro.stat.viewed]]
ACN 633 798 857